3DIcon Presents 3D Visualization Paper for Its CSpace(R) to SPIE Medical Imaging Conference
TULSA, Okla., Feb. 17, 2010 (GLOBE NEWSWIRE) -- 3DIcon Corporation (OTCBB:TDCP), the developer of volumetric, three-dimension projection and display technologies, announced today that it presented on Monday a paper entitled "3D Visualization of Medical Imaging Using Static Volumetric Display – CSpace®" to the Medical Imaging 2010 conference sponsored by SPIE, an international society advancing light-based research. The meeting, being held in San Diego, is the premier conference for medical scientists, physicists, and practitioners in the field of imaging.
Recent developments in medical imaging technologies are assisting radiologists in more accurate diagnoses. 3DIcon's paper details an autostereoscopic static volumetric display, called CSpace®, which is capable of constructing three-dimensional medical imaging data in 3D world coordinates. Using this innovative technology, the displayed 3D data set can be viewed in the transparent medium from any perspective angle without the need of wearing goggles. The design of CSpace®provides a volume rendering of the surface and the interior of any organ of the human body. Accordingly, adjacent tissues can be better monitored, and disease diagnoses can be more accurately diagnosed. In conjunction with CSpace® hardware, 3DIcon has developed a software architecture that can interpret digital imaging and communication in medicine (DICOM) files that can be captured by ultrasound devices, magnetic resonance imaging (MRI), or computed tomography (CT) scanners. With these recent improvements, CSpace® can display the original image in the precise form in which it was captured.
Dr. Hakki Refai, 3DIcon's chief technology officer who coauthored the visualization paper, said, "Using innovative CSpace® technology, when completed, there will no longer be a need for radiologists to mentally reconstruct image slices. Instead, the novel 3D display will preserve spatial correlations between adjacent tissues and then render and scale images to 3D reality. Such medical advancements will allow patients to receive more timely and accurate diagnoses."
3DIcon's paper will be published at the end of the SPIE Medical Imaging conference.
About 3DIcon Corporation
3DIcon Corporation (the "Company") is a developer of groundbreaking 3D projection and display technologies that are designed to produce full color, 360° volumetric images, the "Next Step" in 3D display technologies. The Company recently completed a working prototype of its flagship technology, CSpace®, a breakthrough in 3D imaging, along with concluding a key licensing agreement for the CSpace® technology. 3DIcon has also launched its first software product, Pixel Precision®, which targets the R&D market for developers using Texas Instruments' DLP® line of products. For more information, please visit www.3dicon.net.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION ACT OF 1995
With the exception of historical information, the matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of 3DIcon could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations, inability to hire and retain qualified personnel, and changes in the general economic climate. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by 3DIcon, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.
918-494-0505, extension 304
Released February 17, 2010